An inhibitor of Staphylococcus aureus exfoliative toxin

Eastern Mediterranean Health Journal

Volumn 7, Issue 1-2, 2001, Pages 121-127

  Al Sulami, A A ^a   Al Rubiay, K K ^a   Affat, A M ^b  

^a UNIVERSITY OF BASRAH   (Iraq)

^b SOUTHERN TECHNICAL UNIVERSITY   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITOXIN; CASEIN; EXFOLIATIN; PHOSPHATIDYLCHOLINE; PROTEIN HYDROLYSATE; TRYPTICASE SOY BROTH; TRYPTICASE-SOY BROTH;

ANIMAL; ARTICLE; BACTERIOPHAGE TYPING; BIOASSAY; CLASSIFICATION; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG SCREENING; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMPETIGO; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUSE; STAPHYLOCOCCUS AUREUS; TOXIC EPIDERMAL NECROLYSIS;

ANIMALS; ANTITOXINS; BACTERIOLOGICAL TECHNIQUES; BACTERIOPHAGE TYPING; BIOLOGICAL ASSAY; CASEINS; CULTURE MEDIA; DRUG EVALUATION, PRECLINICAL; EXFOLIATINS; HUMANS; IMPETIGO; MICE; PHOSPHATIDYLCHOLINES; PROTEIN HYDROLYSATES; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; STAPHYLOCOCCUS AUREUS;

EID: 0035241564     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lyell A, Dick HM, Alexander JO. Outbreak of toxic epidermal necrolysis associated with staphylococci. Lancet, 1969, 1(7599):787-9.
2. Melish ME, Glasgow LA. Staphylococcal scalded skin syndrome: the expanded clinical syndrome. Journal of pediatrics, 1971, 78:958-67.
3. Albert S et al. Bullous impetigo due to group II Staphylococcus aureus. American journal of diseases of children, 1970, 120:110-3.
4. Arbuthnott JP, Billcliffe B. Qualitative and quantitative methods for detecting Staphylococcal epidermolytic toxin. Journal of medical microbiology, 1976, 9:191-201.
5. Kaplan MH et al. Importance of exfoliatin toxin A production by Staphylococcus aureus strains isolated from clustered epidemics of neonatal pustulosis. Journal of clinical microbiology, 1986, 23:83-91.
6. Chan HL et al. The incidence of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. A population based study with particular reference to reactions caused by drugs among outpatients. Archives of dermatology, 1990, 126:43-7.
7. Al-Ali SR. A study on staphylococci producing scalded skin syndrome isolated from children [MSc thesis]. University of Baghdad, Iraq, 1993.
8. Steve H. Blistering disorders. New ethical New Zealand's journal practitioner drug treatment. 1994, 31:55-65.
9. Sato H et al. A new type of staphylococcal exfoliative toxin from a Staphylococcus aureus strain isolated from a horse with phlegmon. Infection and immunity, 1994, 62:3780-5.
10. Ladhani S et al. Staphylococcal scalded skin syndrome: exfoliative toxin A (ETA) induces serine protease activity when combined with A431 cells. Acta paediatrica, 1999, 88:776-9.
11. Vath GM et al. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochemistry, 1999, 38:10239-46.
12. Tanabe T et al. Possible receptor for exfoliative toxins produced by Staphylococcus hyicus and Staphylococcus aureus. Infection and immunity, 1995, 64:1591-4.
13. Kloos WE, Bannerman TL. Staphylococcus and micrococcus. In :Murray PR et al., eds. Manual of clinical microbiology, 6th ed. Washington DC, American Society for Microbiology, 1995.
14. Kloos WE, Schleifer KH. Staphylococcus. In: Holt JG et al., eds. Bergey's manual of systematic bacteriology, Vol. 2. Baltimore, Williams and Wilkins Company, 1986.
15. Rogolsky M, Wiely BB, Glasgow LA. Phage group II staphylococcal strains with chromosomal and extrachromosomal genes for exfoliative toxin production. Infection and immunity, 1976, 13:44-52.
16. Kondo I. Research on receptor for staphylococcal exfoliatin. In: Jerliszewicz J, ed. Proceedings of the 4th international symposium on staphylococci and staphylococcal infections. Stuttgart, 1980.
17. Whitelaw DD, Birkbeck TH. Inhibition of staphylococcal delta hemolysin by serum lipoproteins. FEMS microbiology letters, 1978, 3:335-8.